lung
transplant
recipi
present
increas
risk
sever
complic
associ
respiratori
infect
conduct
review
literatur
examin
clinic
relationship
viral
respiratori
infect
graft
complic
thirtyfour
studi
describ
clinic
impact
influenza
respiratori
syncyti
viru
parainfluenza
human
metapneumoviru
rhinoviru
enteroviru
coronaviru
bocaviru
adenoviru
identifi
detect
rate
respiratori
viral
infect
rang
virus
detect
five
time
frequent
respiratori
symptom
present
odd
ratio
ci
base
avail
observ
could
observ
associ
respiratori
viral
infect
acut
reject
ci
found
pool
incid
bronchiol
obliteran
syndrom
bo
virusposit
case
compar
virusneg
case
howev
limit
number
bo
event
allow
confirm
associ
review
confirm
causal
relationship
respiratori
virus
respiratori
symptom
confirm
link
respiratori
virus
acut
lung
reject
relat
part
heterogen
limit
avail
studi
link
bo
need
also
reassess
appropri
prospect
studi
abbrevi
odd
ratio
bo
bronchiol
obliteran
syndrom
rsv
respiratori
synctial
viru
piv
parainfluenza
viru
hmpv
human
metapneumoviru
ltr
lung
transplant
recipi
pcr
polymeras
chain
reaction
ci
confid
interv
icu
intens
care
unit
bal
bronchoalveolar
lavag
fev
forc
expiratori
volum
sec
ob
oblit
bronchiol
respiratori
virus
compris
differ
virus
influenza
respiratori
synctial
viru
rsv
parainfluenza
piv
human
metapneumoviru
hmpv
rhinoviru
enteroviru
bocaviru
adenoviru
although
respiratori
viral
infect
caus
selflimit
upper
respiratori
diseas
lung
transplant
recipi
ltr
particularli
prone
develop
complic
relat
immunosuppress
therapi
could
promot
protract
infect
also
direct
exposur
graft
infecti
agent
togeth
impair
mucociliari
function
lymphat
drainag
absenc
cough
reflex
apart
direct
infectionrel
morbid
commonli
accept
infect
could
promot
reject
subsequ
lead
bronchiol
obliteran
syndrom
bo
main
limit
longterm
surviv
howev
associ
base
report
focus
mainli
paramyxovirus
influenza
adenoviru
lesser
extent
studi
heterogen
sever
technic
limit
term
design
case
select
diagnost
procedur
year
improv
molecular
tool
includ
realtim
pcr
technolog
contribut
increas
sensit
diagnost
procedur
new
speci
hmpv
coronaviru
bocaviru
rhinoviru
c
also
emerg
assess
appropri
evid
support
role
respiratori
virus
caus
symptom
graft
complic
ltr
conduct
systemat
review
publish
literatur
search
medlin
databas
januari
march
use
follow
key
word
lung
transplant
recipi
immunocompromis
host
influenza
parainfluenza
rsv
metapneumoviru
coronaviru
bocaviru
adenoviru
respiratori
virus
respect
addit
refer
list
review
articl
select
paper
handsearch
match
databas
peerreview
origin
articl
report
least
three
lung
transplant
case
descript
virolog
method
design
clinic
endpoint
includ
data
collect
standard
report
form
follow
inform
year
screen
period
design
cohort
case
seri
retrospect
prospect
age
size
popul
screen
number
type
specimensvirus
test
number
virusposit
episod
analyz
type
assay
use
clinic
condit
associ
acut
rejectionchron
rejectionbo
histopatholog
result
antivir
treatment
surviv
rate
potenti
limit
comment
consid
relev
note
calcul
confid
interv
ci
around
proport
studi
viral
frequenc
use
agresti
coull
method
odd
ratio
calcul
studi
determin
associ
respiratori
virus
acut
reject
respiratori
symptom
due
signific
heterogen
studi
use
random
effect
model
calcul
metaanalyt
summari
associ
respiratori
virus
acut
reject
respiratori
symptom
analys
perform
stata
colleg
station
tx
usa
identifi
studi
focus
ltr
eight
analyz
also
immunocompromis
popul
virus
consid
review
cover
influenza
b
c
rsv
b
piv
hmpv
rhinoviru
enteroviru
coronaviru
bocaviru
adenoviru
herp
virus
main
characterist
studi
present
tabl
estim
specimen
ltr
screen
presenc
least
one
abovement
respiratori
virus
approxim
onethird
studi
screen
within
frame
prospect
cohort
studi
investig
caus
andor
clinic
impact
acut
viral
respiratori
tract
infect
other
retrospect
case
seri
studi
patient
recruit
outpati
clinic
six
patient
hospit
one
recruit
inand
outpati
recruit
set
could
determin
precis
remain
six
diagnost
procedur
perform
symptomat
patient
studi
also
perform
routin
posttranspl
surveil
control
procedur
treatment
acut
reject
reason
procedur
identifi
two
retrospect
studi
studi
concern
children
enrol
children
adult
adult
clinic
condit
analyz
rang
uncompl
upper
respiratori
tract
infect
sever
pneumonia
requir
intens
care
unit
icu
admiss
overal
possibl
identifi
viral
investig
perform
upper
respiratori
specimen
nasopharyng
swab
aspir
studi
bronchoalveolar
lavag
bal
specimen
type
specimen
use
remain
studi
possibl
clearli
establish
respect
proport
upper
versu
lower
respiratori
specimen
identifi
one
studi
compar
systemat
upper
versu
lower
respiratori
tract
viral
screen
perform
simultan
given
individu
thu
unabl
compar
respect
sensit
role
viral
screen
upper
versu
lower
respiratori
tract
expect
signific
heterogen
differ
diagnost
procedur
use
least
one
molecular
assay
use
investig
five
studi
use
larg
panel
target
least
abovement
virus
older
studi
classic
method
immunofluoresc
viral
cultur
sole
diagnost
tool
type
techniqu
use
immunofluorescencebas
cultur
nucleic
acid
detect
complet
screen
perform
avail
studi
select
shown
tabl
term
viral
screen
influenza
screen
studi
influenza
b
respect
influenza
c
follow
rsv
piv
piv
adenoviru
respiratori
virus
requir
mainli
molecular
assay
detect
less
frequent
screen
rhinoviru
rhinoviru
c
screen
one
studi
hmpv
differ
subtyp
coronavirus
enteroviru
bocaviru
overal
studi
screen
least
respiratori
virus
list
tabl
assess
overal
detect
rate
respiratori
viral
infect
screen
popul
vari
wide
rang
explain
part
heterogen
popul
enrol
asymptomat
case
versu
subject
limit
upper
respiratori
symptom
versu
patient
hospit
complic
tabl
depict
preval
viru
posit
individu
studi
pool
preval
accord
diagnost
method
number
virus
screen
sampl
size
expect
viru
posit
rate
higher
studi
small
sampl
size
use
pcr
techniqu
screen
numer
virus
exampl
studi
use
pcr
techniqu
higher
detect
rate
compar
use
pcr
explain
part
greater
number
virus
search
pcr
techniqu
studi
identifi
nine
virus
identifi
eight
less
virus
respect
contribut
speci
posit
case
avail
studi
larg
panel
molecular
tool
use
virus
frequent
detect
rhinoviru
coronaviru
three
studi
continu
screen
least
respiratori
virus
rhinoviru
repres
posit
case
coronavirus
includ
three
supplementari
studi
screen
virus
frequent
viru
detect
still
rhinoviru
tabl
note
target
coronavirus
speci
includ
ten
studi
compar
rate
viral
infect
observ
symptomat
case
versu
without
respiratori
symptom
found
smaller
studi
tend
includ
symptomat
patient
larger
studi
associ
lower
viru
detect
rate
studi
less
specimen
versu
studi
specimen
tabl
figur
highlight
one
studi
associ
laboratoryproven
respiratori
virus
symptom
present
found
virus
detect
five
time
frequent
respiratori
symptom
present
ci
term
object
assess
graft
function
acut
phase
lung
function
assess
avail
studi
show
forc
expiratori
volum
fev
declin
rang
overal
enrol
popul
fev
declin
usual
similar
even
import
among
symptomat
patient
studi
provid
specif
comparison
fev
variabl
accord
presenc
absenc
viral
ill
prevent
analysi
shortterm
crude
mortal
rate
evalu
studi
rang
antivir
treatment
use
studi
mostli
ribavirin
rsv
infect
also
neuraminidas
inhibitor
amantadin
influenza
infect
studi
discuss
treatment
efficaci
consid
treatment
efficaci
endpoint
base
clinic
outcom
treat
subject
report
earli
antivir
therapi
might
associ
reduct
complic
mortal
nevertheless
given
small
number
case
lack
random
appropri
control
group
absenc
analysi
report
precis
rate
reduct
mortal
andor
morbid
trend
could
consid
non
evidencebas
conclus
twentyf
studi
repres
ltr
specimen
report
transbronchi
lung
biopsi
perform
total
patholog
examin
potenti
avail
howev
presenc
acut
reject
oblit
bronchiol
ob
report
case
respect
among
total
virusposit
virusneg
case
overal
ci
biopsyproven
biopsyproven
fev
declin
random
effect
result
acut
reject
rate
three
studi
suitabl
present
analysi
thu
leav
studi
report
total
acut
reject
event
grade
investig
frequenc
acut
reject
rang
tabl
associ
acut
reject
estim
compar
rate
observ
virusposit
case
one
observ
virusneg
case
avail
four
studi
one
studi
suggest
signific
posit
associ
could
confirm
three
other
figur
overal
found
statist
signific
associ
respiratori
virus
acut
reject
ci
obbo
incid
follow
respiratori
viral
infect
report
period
time
rang
month
year
studi
except
one
use
either
biopsyproven
chronic
reject
defin
presenc
ob
sustain
fev
declin
accord
intern
societi
heart
lung
transplant
guidelin
bo
incid
tabl
follow
respiratori
viral
infect
rang
virusposit
case
report
three
studi
virusneg
case
rate
rang
pool
incid
rate
three
studi
reveal
bo
incid
virusposit
case
compar
virusneg
case
low
number
bo
event
analyz
three
investig
limit
abil
provid
metaanalyt
summari
could
consid
relev
four
studi
tabl
provid
statist
analysi
test
potenti
associ
bo
two
without
provid
clearli
bo
rate
virusneg
case
one
fail
show
signific
associ
three
describ
signific
higher
rate
bo
subject
experienc
respiratori
viral
infect
season
peak
ltr
live
commun
expos
rna
dna
respiratori
virus
given
concomit
presenc
signific
immunosuppress
impair
protect
mechan
graft
lung
viral
infect
promot
complic
graft
reject
present
review
studi
goal
assess
strength
characterist
associ
avail
clinic
report
whether
translat
observ
associ
reallif
condit
incomplet
microbiolog
investig
insensit
diagnost
tool
limit
complet
viral
investig
recent
report
use
larg
panel
molecular
test
provid
less
bias
imag
respect
role
viral
agent
earli
studi
use
mainli
viral
cultur
direct
immunofluoresc
avail
pcr
limit
influenza
rsv
parainfluenza
virus
recent
emerg
new
virus
hmpv
coronaviru
coronaviru
bocaviru
human
rhinoviru
c
need
includ
modern
molecular
panel
new
agent
systemat
studi
two
studi
interestingli
test
socal
common
cold
virus
like
rhinovirus
coronaviru
reveal
frequent
compar
other
influenza
paramyxovirus
observ
consist
hospitalbas
studi
depend
type
number
techniqu
use
size
studi
enrol
criteria
observ
frequenc
viral
infect
dramat
changerang
individu
viru
less
pool
analysi
tabl
clinic
signific
posit
viral
nucleic
acid
detect
result
critic
point
need
confront
presenc
absenc
respiratori
symptom
type
analysi
done
least
studi
tabl
figur
ltr
submit
routin
respiratori
screen
graft
followup
use
control
compar
symptomat
case
consist
shown
presenc
viral
infect
likelihood
respiratori
symptom
five
time
higher
observ
could
guid
clinician
interpret
microbiolog
result
era
increasingli
sensit
molecular
diagnost
panel
avail
even
background
posit
rate
expect
exampl
follow
unnot
asymptomat
infect
season
outbreak
ongo
commun
virus
like
contribut
symptom
product
case
regard
innoc
bystand
although
mainli
expect
upper
respiratori
tract
viral
infect
also
present
lower
respiratori
specimen
rais
sever
issu
respect
abil
respiratori
viru
infect
lower
respiratori
tract
whether
consid
equal
abl
caus
graft
complic
ltr
despit
expect
pool
analysi
unabl
confirm
posit
associ
acut
reject
previou
viral
infect
howev
conclus
need
consid
care
sinc
three
largest
studi
repres
case
brought
discord
result
two
fail
observ
posit
associ
wherea
third
report
reject
rate
virusposit
case
compar
virusneg
case
p
valu
note
latter
studi
consid
biopsyproven
case
reject
criteria
also
fev
declin
anoth
potenti
limit
pool
analysi
relat
heterogen
design
studi
report
acut
reject
rate
acut
phase
viral
infect
other
followup
period
month
although
present
report
focus
respiratori
virus
must
also
kept
mind
agent
could
associ
promot
bacteri
fungal
infect
subsequ
could
lead
graft
complic
regard
chronic
reject
relationship
previou
respiratori
viral
infect
subsequ
develop
bo
report
statist
signific
three
studi
least
seven
studi
bo
incid
evalu
discuss
risk
could
link
respiratori
virus
evalu
median
number
virusposit
case
studi
bo
analyz
five
rang
four
studi
compar
rate
virusposit
versu
neg
case
total
nine
bo
event
virusposit
case
tabl
low
number
event
incomplet
heterogen
retrospect
design
publish
report
allow
us
conduct
appropri
statist
analysi
note
studi
suggest
select
virus
rsv
piv
influenza
possibl
hmpv
particularli
prone
trigger
graft
reject
studi
control
group
incomplet
thu
clinic
relationship
one
specif
respiratori
viral
famili
graft
reject
need
reconsid
care
conclus
review
confirm
causal
relationship
respiratori
viral
infect
respiratori
symptom
even
infect
document
molecular
assay
howev
respect
role
respiratori
viru
especi
respect
picornaand
coronaviru
need
reconsid
although
certain
lower
respiratori
viral
infect
promot
graft
complic
highlight
clinic
link
respiratori
virus
acut
lung
reject
bo
need
character
prospect
appropri
design
cohort
studi
addit
support
inform
may
found
onlin
version
articl
tabl
rel
proport
virusposit
case
accord
presenc
respiratori
symptom
lung
transplant
recipi
screen
respiratori
virus
tabl
summari
studi
analyz
potenti
associ
acut
reject
respiratori
viral
infect
lung
transplant
recipi
pleas
note
wileyblackwel
respons
content
function
support
materi
suppli
author
queri
miss
materi
direct
correspond
articl
